Table 4.
Age (years) | 2014, n (%a) | 2015, n (%a) | 2016, n (%a) | 2017, n (%a) | 2018, n (%a) | P value for trend |
---|---|---|---|---|---|---|
HPV positive | ||||||
< 30 | 47 (18.73) | 183 (20.42) | 208 (23.27) | 344 (23.53) | 216 (22.27) | 0.0002 |
30–40 | 91 (36.25) | 312 (34.82) | 305 (34.12) | 473 (32.35) | 386 (39.79) | < 0.0001 |
40–50 | 48 (19.12) | 201 (22.43) | 175 (19.57) | 339 (23.19) | 186 (19.18) | 0.0596 |
50–60 | 45 (17.93) | 133 (14.84) | 152 (17.00) | 222 (15.18) | 127 (13.09) | 0.879 |
> 60 | 20 (7.97) | 67 (7.48) | 54 (6.04) | 84 (5.75) | 55 (5.67) | 0.4306 |
Total | 251 | 896 | 894 | 1462 | 970 | – |
TCT positive | ||||||
< 30 | 25 (18.12) | 69 (16.67) | 81 (19.52) | 101 (19.13) | 48 (19.12) | 0.0541 |
30–40 | 48 (34.78) | 131 (31.64) | 147 (35.42) | 170 (32.20) | 104 (41.43) | 0.016 |
40–50 | 32 (23.19) | 118 (28.50) | 96 (23.13) | 144 (27.27) | 49 (19.52) | < 0.0001 |
50–60 | 26 (18.84) | 61 (14.73) | 67 (16.14) | 80 (15.15) | 34 (13.55) | 0.001 |
> 60 | 7 (5.07) | 35 (8.45) | 24 (5.78) | 33 (6.25) | 16 (6.37) | 0.0385 |
Total | 138 | 414 | 415 | 528 | 251 | – |
HPV human papillomavirus, TCT thinprep cytology test
a Represented the percentage of HPV infection rates in different groups